Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Baxter lives in fear of a bigger fish going over the top.

<< Previous

Bullboard Posts

Next >>

Comment by BlueJays9293on Jan 17, 2024 8:05pm

159 Views

Post# 35832578

RE:RE:RE:Baxter lives in fear of a bigger fish going over the top.

Just the fact that the FDA gave Euphrates a second bite at the apple,

in almost a carte blanche way,

based on the purity with how Eupharates was run completely blinded to the utmost,

based on the solemnity of the sub-group analysis,

and it's untainted rationale of logic,

is amazeballs for the FDA.

It reminds me of Sally Fields Oscar accetance speech.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market